Northside Hospital, Inc - GCS/Canton — Canton, Georgia

Northside Hospital, Inc - GCS/Canton is a clinical research site located in Canton, Georgia, United States 30115.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Northside Hospital, Inc - GCS/Canton has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Canton

Browse all research sites in Georgia · View every site in Canton

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital, Inc - GCS/Canton?

Northside Hospital, Inc - GCS/Canton has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital, Inc - GCS/Canton conducted?

Northside Hospital, Inc - GCS/Canton has 4 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.

Is Northside Hospital, Inc - GCS/Canton accredited by Crixeo Clinical Trials?

Northside Hospital, Inc - GCS/Canton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital, Inc - GCS/Canton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.